Home - Products - Others - Other Targets - (Ala11·22·28)-VIP (human, bovine, porcine, rat)

(Ala11·22·28)-VIP (human, bovine, porcine, rat)

CAS No. 291524-04-4

(Ala11·22·28)-VIP (human, bovine, porcine, rat)( ——— )

Catalog No. M40479 CAS No. 291524-04-4

(Ala11·22·28)-VIP (human, bovine, porcine, rat)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 1223 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Ala11·22·28)-VIP (human, bovine, porcine, rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    (Ala11·22·28)-VIP (human, bovine, porcine, rat)
  • Description
    (Ala11·22·28)-VIP (human, bovine, porcine, rat)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    291524-04-4
  • Formula Weight
    3160.7
  • Molecular Formula
    C139H231N43O39S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sarafotoxin S6d

    Sarafotoxin S6d

  • Helecin

    Helicin is a beta-D-glucoside resultng from the oxidation of the benzylic hydroxy group of salicin to the corresponding aldehyde. It has a role as a metabolite. It is a member of benzaldehydes a beta-D-glucoside and a monosaccharide derivative.

  • Nogo-66 (1-40)

    Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.